BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22418021)

  • 1. [18F]FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin.
    Stojanov K; de Vries EF; Hoekstra D; van Waarde A; Dierckx RA; Zuhorn IS
    Mol Imaging; 2012 Feb; 11(1):1-12. PubMed ID: 22418021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography.
    Zhang Y; Thorn S; DaSilva JN; Lamoureux M; DeKemp RA; Beanlands RS; Ruel M; Suuronen EJ
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):197-204. PubMed ID: 19808543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability and proliferation potential of adipose-derived stem cells following labeling with a positron-emitting radiotracer.
    Elhami E; Goertzen AL; Xiang B; Deng J; Stillwell C; Mzengeza S; Arora RC; Freed D; Tian G
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1323-34. PubMed ID: 21380591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
    Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS
    J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
    Roivainen A; Parkkola R; Yli-Kerttula T; Lehikoinen P; Viljanen T; Möttönen T; Nuutila P; Minn H
    Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.
    Zhang Y; Dasilva JN; Hadizad T; Thorn S; Kuraitis D; Renaud JM; Ahmadi A; Kordos M; Dekemp RA; Beanlands RS; Suuronen EJ; Ruel M
    Cell Transplant; 2012; 21(9):1821-35. PubMed ID: 22469629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity.
    Wolfs E; Struys T; Notelaers T; Roberts SJ; Sohni A; Bormans G; Van Laere K; Luyten FP; Gheysens O; Lambrichts I; Verfaillie CM; Deroose CM
    J Nucl Med; 2013 Mar; 54(3):447-54. PubMed ID: 23353687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of 1-O-(4-(2-fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-D-glucopyronuronate: a positron emission tomographic tracer for imaging β-glucuronidase activity in a tumor/inflammation rodent model.
    Antunes IF; Haisma HJ; Elsinga PH; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    Mol Imaging; 2012 Feb; 11(1):77-87, E1. PubMed ID: 22418030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.
    Adonai N; Adonai N; Nguyen KN; Walsh J; Iyer M; Toyokuni T; Phelps ME; McCarthy T; McCarthy DW; Gambhir SS
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3030-5. PubMed ID: 11867752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species.
    Nose N; Nogami S; Koshino K; Chen X; Werner RA; Kashima S; Rowe SP; Lapa C; Fukuchi K; Higuchi T
    Sci Rep; 2021 May; 11(1):10896. PubMed ID: 34035416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging pulmonary inflammation with positron emission tomography: a biomarker for drug development.
    Chen DL; Schuster DP
    Mol Pharm; 2006; 3(5):488-95. PubMed ID: 17009847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo.
    Hucklenbroich J; Klein R; Neumaier B; Graf R; Fink GR; Schroeter M; Rueger MA
    Stem Cell Res Ther; 2014 Sep; 5(4):100. PubMed ID: 25928248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of cell therapy for gastroenterologic applications.
    Dimayuga VM; Rodriguez-Porcel M
    Pancreatology; 2011; 11(4):414-27. PubMed ID: 21912197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    Cheng SH; Yu D; Tsai HM; Morshed RA; Kanojia D; Lo LW; Leoni L; Govind Y; Zhang L; Aboody KS; Lesniak MS; Chen CT; Balyasnikova IV
    J Nucl Med; 2016 Feb; 57(2):279-84. PubMed ID: 26564318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC and TLC methods for analysis of [
    Rokka J; Grönroos TJ; Viljanen T; Solin O; Haaparanta-Solin M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():140-149. PubMed ID: 28236580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.